Sponsor This PageClick here to find out how

Apixaban Prevents Stroke for Patients with Atrial Fibrillation

The FDA recently approved the drug Apixaban to prevent strokes in patients with nonvalvular atrial fibrillation. Afib is the most common form of cardiac arrhythmia, an irregular heart beat, and is associated with congestive heart failure and an increased risk of stroke. Apixaban works by preventing blood clots that could break away into other parts of the body and cause strokes.

Apixaban has been approved for cases of Afib that are specifically not caused by heart valve problems. Patients with prosthetic heart valves should not take Apixaban. The most serious risk currently associated with Apixaban, as well as other anticoagulants, is the risk of life-threatening bleeding.

Approval for the medication is based largely on a study comparing Apixaban to other comparable anticoagulants, in which Apixaban proved more effective for preventing strokes.

Apixaban will be sold under the name Eliquis. Anyone interested in the drug should consult a health care professional.

By: Kayleen Cohen, Stroke-Network.com

^ back to top

"Apixaban works by preventing blood clots that could break away into other parts of the body and cause strokes."

More on Prevention

For more information on stroke prevention check out these articles on reducing risk through lifestyle adjustments and medical intervention.

Tomatoes Reduces Risk

Recent studies have shown that eating tomatoes and tomato-based foods is associated with a lower risk of stroke. Learn more here.

A Glass a Day...

According to new research, light-to-moderate alcohol consumption is associated with a lower risk of stroke in women. Learn more here.

Harch Hyperbarics Empower Services Your Ad Here